Inhibition of melanogenesis and melanoma metastasis with p-aminobenzoic acid (PABA)
AssigneeNew York University
InventorsPeter C. Brooks, Danielle Morais, Dorothy Rodriguez
Life of this patent
Estimating the term…
Abstract
The present invention relates to the inhibition of melanogenesis with para-aminobenzoic acid (PABA) and its use in treating melanotic cancer.
Claims30
A method of inhibiting melanogenesis which comprises administering an effective amount of PABA for inhibiting melanogenesis to a mammal in need of such treatment.
A method of treating melanotic cancer comprising administering an effective amount of PABA for treating melanotic cancer to a mammal in need of such treatment.
A method for treating a patient with malignant melanoma comprising administering a combination of carboplatin, paclitaxel, and PABA.
An oral dosage form comprising PABA and a pharmaceutically acceptable carrier.
A parenteral dosage form comprising PABA and a liquid carrier.
An oral dosage form for the treatment of melanoma in a patient afflicted with melanoma consisting essentially of administering PABA.
A parenteral dosage form for the treatment of melanoma in a patient afflicted with melanoma consisting essentially of administering PABA.
A method for treating a human afflicted with melanoma comprising administering an effective amount of PABA.
Dependencies are inferred from the claim text.